meta-hydroxyephedrine
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2015 (NCT02669563)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 11-carbon
Oral
No
Parenteral
No
Topical
No
Also known as
- 11c-hydroxyephedrine-meta
- 11c-meta-hydroxyephedrine
- 3-hydroxyephedrine
- hcl(r-(r*,s*))-isomer of 3-hydroxyephedrine
- meta-hydroxyephedrine
- meta-hydroxyephedrine
- meta-hydroxyephedrine
- m-hydroxyephedrine
- r-(r*,s*)-isomer of 3-hydroxyephedrine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03388788 | Early Phase 1 (Phase 1) | May 1, 2018 | Oregon Health and Science University |
| NCT02962076 | N/A | Dec 1, 2016 | Biosense Webster, Inc., Mercy Health Research, Mercy Research, Washington University in St. Louis |
| NCT02669563 | Early Phase 1 (Phase 1) | Dec 1, 2015 | University of Michigan |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biosense Webster, Inc. | For profit | 1 | 0 | 1 | 2016 |
| Mercy Health Research | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Mercy Research | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Oregon Health and Science University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Washington University in St. Louis | Academic/Hospital | 1 | 0 | 1 | 2016 |
6 organizations
Page 1 / 1